NNVC · Nanoviricides, Inc. · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“As a result, substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-K filed Sep 28, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2022-08-08 | Diwan Anil |
Director, President |
Gift↓
Filing footnotes — Common Stock, par value $0.001 per share (Direct)
The reported transaction involves a gift made by the reporting person for estate planning purposes to an irrevocable trust whose beneficiaries are his minor children and of which he is neither the trustee nor a beneficiary. Does not include 6,074 shares of Series A Convertible Preferred Stock (the "Series A Stock") owned by the reporting person which is convertible into three and one-half shares of common stock upon limited conditions. Does not include 200,000 shares of Series A Stock or 470,959 shares of common stock owned by TheraCour Pharma, Inc., over which the reporting person holds voting and dispositive power. |
Common Stock, par value $0.001 per share
|
94,471 |